Yellowish glow in low‑light vision (photopsia) - Causes, Treatment & When to See a Doctor

```html

What is Yellowish Glow in Low‑Light Vision (Photopsia)?

Photopsia is the medical term for brief flashes, flickers, or streaks of light that appear in the visual field without an external source. When the perceived light has a distinct yellowish hue and becomes most noticeable in dim environments, patients often describe it as a “yellowish glow” that seems to emanate from the periphery or central vision. This phenomenon is usually caused by abnormal electrical activity within the retina or the visual pathways of the brain.

While occasional, isolated photopsia can be benign (for example, after vigorous eye rubbing), a persistent or recurrent yellow‑tinged glow may signal an underlying ocular or neurological condition that warrants evaluation. Understanding the possible causes, accompanying symptoms, and when to seek care can help prevent vision loss or more serious complications.

Common Causes

Below are the most frequent conditions associated with a yellowish glow in low‑light vision. They are grouped by ocular versus systemic origins.

• Posterior Vitreous Detachment (PVD) – The gel‑like vitreous humor pulls away from the retina, stimulating retinal cells and producing flashes that can appear yellow.
• Retinal Tears or Holes – Traction on the retina from a vitreous detachment or trauma can cause photopsia; the yellow tint may result from altered photoreceptor stimulation.
• Age‑Related Macular Degeneration (AMD) – Advanced dry or neovascular AMD can create scotomas that are perceived as yellowish glows, especially in low‑light situations.
• Diabetic Retinopathy – Microvascular changes and retinal ischemia can lead to phosphorescent‑like visual phenomena.
• Posterior Uveitis / Inflammatory Conditions – Inflammation of the retina or choroid can alter the way light is processed, sometimes producing a yellow glow.
• Migraine‑Associated Aura – Visual auras may include shimmering yellow lights that are more apparent in darkness.
• Optic Neuritis – Inflammation of the optic nerve can cause transient visual flashes, frequently described as yellow or amber.
• Medication Side‑Effects – Certain drugs (e.g., sildenafil, anticholinergics, some antidepressants) can affect retinal neurotransmission and create photopsia.
• Retinal or Choroidal Tumors – Rarely, a growing lesion may stimulate surrounding retinal tissue, resulting in colorful flashes.
• Neurological Disorders – Lesions in the occipital cortex, epilepsy, or multiple sclerosis can produce visual disturbances that include yellowish lights.

Associated Symptoms

Photopsia rarely occurs in isolation. The following symptoms often accompany a yellowish glow and can help clinicians narrow the diagnosis:

• Floaters – Small, moving specks or cobweb‑like shadows that drift across the field of view.
• Decreased visual acuity – Blurring or a “foggy” sensation, especially central vision.
• Peripheral visual field loss – Noticing shadows or “curtains” at the edge of vision.
• Eye pain or pressure – Particularly with uveitis, optic neuritis, or acute glaucoma.
• Headache or migraine aura – Often throbbing pain preceding or accompanying the visual change.
• Photophobia – Increased sensitivity to light.
• Colour distortion (metamorphopsia) – Straight lines appearing wavy or objects changing hue.
• Systemic signs – Fever, joint pain, or rash may suggest an inflammatory or infectious cause.

When to See a Doctor

Because some causes of photopsia can lead to permanent vision loss, prompt medical attention is essential when any of the following arise:

• Sudden onset of flashes accompanied by new or increasing floaters.
• Any change in visual acuity, especially if it worsens over days.
• Peripheral “shadow” or curtain feeling that expands rapidly.
• Eye pain, redness, or swelling.
• Persistent yellow glow lasting more than a few minutes or occurring daily.
• History of diabetes, high myopia, recent eye trauma, or prior retinal surgery.
• Neurological symptoms such as weakness, speech difficulty, or severe headache.

Even if the glow seems mild, individuals with risk factors (e.g., age > 50, high myopia > 6 D, known retinal disease) should schedule an eye exam within 24‑48 hours.

Diagnosis

Evaluation begins with a thorough history and a focused eye examination. Typical steps include:

1. Detailed History

• Onset, frequency, duration, and description of the glow.
• Associated visual symptoms (floaters, loss of vision, colour changes).
• Systemic health, medication list, recent trauma, and family eye‑disease history.

2. Visual Acuity & Refraction

Standard eye‑chart testing to establish baseline vision and determine if refractive error contributes.

3. Dilated Fundus Examination

Using ophthalmoscopy or a slit‑lamp with a fundus lens, the clinician inspects the retina for tears, holes, drusen, hemorrhages, or inflammatory cells.

4. Optical Coherence Tomography (OCT)

A non‑invasive scan that provides cross‑sectional images of the retina and vitreous, identifying subtle tears, macular edema, or neovascular membranes.

5. Ultra‑widefield or Fundus Photography

Documents retinal pathology and helps monitor progression over time.

6. Fluorescein Angiography (FA) or Indocyanine Green Angiography (ICG)

Used when vascular leakage, choroidal neovascularization, or inflammatory lesions are suspected.

7. Visual Field Testing

Automated perimetry can detect peripheral field loss linked to retinal detachment or optic nerve disease.

8. Neurological Work‑up (if indicated)

• Magnetic Resonance Imaging (MRI) of the brain and orbits – to rule out occipital lesions, demyelination, or compressive optic neuropathy.
• Blood tests – HbA1c, inflammatory markers (ESR, CRP), autoimmune panels, Lyme serology, depending on clinical suspicion.

Treatment Options

Treatment is tailored to the underlying cause. Below is a summary of typical interventions.

Retinal Tear or Detachment

• Laser Photocoagulation – Seals small retinal tears to prevent progression.
• Scleral Buckle or Vitrectomy – Surgical repair for larger detachment.
• Post‑procedure positioning (face‑down) to allow the retina to re‑attach.

Posterior Vitreous Detachment (without tear)

• Observation – Most PVDs resolve without intervention; patients are instructed to monitor for new flashes or floaters.
• Patient education on warning signs (see “Emergency Warning Signs”).

Age‑Related Macular Degeneration

• Dry AMD – Nutritional supplements (AREDS2 formula: vitamin C, vitamin E, zinc, copper, lutein, zeaxanthin).
• Wet AMD – Anti‑VEGF intravitreal injections (e.g., ranibizumab, aflibercept) to halt neovascular growth.

Diabetic Retinopathy

• Optimise blood‑glucose, blood‑pressure, and lipid control.
• Laser photocoagulation for proliferative disease.
• Anti‑VEGF injections for macular edema.

Uveitis / Inflammatory Conditions

• Corticosteroid eye drops or peri‑ocular injections for mild disease.
• Systemic steroids or immunomodulatory therapy for severe or chronic inflammation.

Migraine Aura

• Acute abortive therapy – Triptans or NSAIDs.
• Preventive medications – β‑blockers, calcium‑channel blockers, topiramate, or CGRP antagonists.
• Lifestyle modifications – regular sleep, hydration, avoidance of known triggers.

Medication‑Induced Photopsia

• Review and adjust offending drugs in consultation with prescribing physician.
• Consider dose reduction or alternative agents.

Neurological Causes

• Seizure control – antiepileptic drugs if cortical irritation is identified.
• MS management – disease‑modifying therapies.
• Referral to neurology for further work‑up.

Supportive & Home Measures

• Maintain a well‑lit environment when moving around at night to reduce visual strain.
• Use protective eyewear to avoid trauma.
• Adopt a balanced diet rich in omega‑3 fatty acids, leafy greens, and antioxidants (support retinal health).
• Control systemic risk factors – smoking cessation, blood‑sugar monitoring, blood‑pressure control.

Prevention Tips

While not all causes are preventable, many risk factors can be modified:

• Regular Eye Exams – Dilated examinations annually after age 40, or sooner if you have diabetes, high myopia, or a family history of retinal disease.
• Protect Your Eyes – Wear sunglasses with UV protection and safety goggles during high‑risk activities.
• Manage Chronic Conditions – Keep diabetes, hypertension, and hyperlipidemia under control to reduce retinal vascular damage.
• Stay Hydrated & Rested – Dehydration and extreme fatigue can increase migraine frequency and ocular strain.
• Avoid Smoking – Smoking accelerates AMD and vascular disease.
• Limit Excessive Screen Time – Follow the 20‑20‑20 rule (every 20 minutes, look at something 20 feet away for 20 seconds) to reduce eye fatigue.
• Monitor Medications – Inform your physician about visual side‑effects; periodic vision screening may be advised for drugs known to affect the retina.

Emergency Warning Signs

Key Take‑aways

A yellowish glow in low‑light conditions is a form of photopsia that can range from benign to sight‑threatening. Recognizing accompanying signs, seeking timely professional evaluation, and managing underlying health issues are essential steps to protect your vision.

For further reading, consult reputable sources such as the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```